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Effect of Dietary Soy Genistein on Pig Growth and Immune Response
during a Viral Challenge
Abstract
Twelve replications of four littermate pigs from a herd naive for porcine reproductive and respiratory
syndrome (PRRS) were weaned (10 ± 2 d of age) and penned individually in disease isolation rooms. Pigs
were randomly allotted within litter to one of four dietary concentrations of soy genistein (0, 200, 400, 800
ppm) to quantify the effect of genistein on growth and immune response during a viral challenge. Genistein
was provided as the soy glycoside, genistin. At 29 ± 2 d of age (4.9 ± 1.4 kg BW), pigs were oronasally
inoculated with 104.3 PRRS virus/mL from strain JA142 in a 2-mL dose. Blood was collected every 4 d from d
0 to 24 postinoculation (PI) and analyzed for serum PPRS virus, interferon (IFN) activity, and
alpha-1-acylglycoprotein (AGP) concentrations. Serum virus and IFN peaked at 105 virus/mL and 57%
protection, respectively, at 4 d PI and then declined steadily. Serum AGP concentration peaked at 12 d PI. As
dietary genistein concentration increased, serum concentrations of PRRS virus decreased linearly (102.46,
102.26, 102.05, 102.14 virus per mL of serum, P < .07) and IFN responded quadratically (28.4, 25.7, 22.8,
30.9% protection, P < .06) independent of d PI. AGP concentrations increased (P < .01) quadratically with
the magnitude of the response to dietary genistein maximized at 12 to 16 d PI. Effects of dietary genistein on
daily pig gain and feed intake were dependent on dietary genistein concentration and stage of viremia. Daily
pig gains from d 0 to 24 postinoculation were improved quadratically (243, 281, 250, 246 g, P < .07) as
dietary genistein increased, but the magnitude of the response to dietary genistein concentration lessened as
the serum virus concentrations were minimized. Daily feed intakes also were improved quadratically (315,
371, 345, 317 g, P < .05) as genistein concentration increased. These data indicate that dietary soy genistein at
200 to 400 ppm is an orally active immune modulator that enhances systemic serum virus elimination and
body growth in virally challenged pigs.
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Summary and Implications
Twelve replications of four littermate pigs from a
herd naive for porcine reproductive and respiratory
syndrome (PRRS) were weaned (10 ± 2 d of age) and
penned individually in disease isolation rooms.  Pigs were
randomly allotted within litter to one of four dietary
concentrations of soy genistein (0, 200, 400, 800 ppm) to
quantify the effect of genistein on growth and immune
response during a viral challenge.  Genistein was
provided as the soy glycoside, genistin.  At 29 ± 2 d of
age (4.9 ± 1.4 kg BW), pigs were oronasally inoculated
with 104.3 PRRS virus/mL from strain JA142 in a 2-mL
dose.  Blood was collected every 4 d from d 0 to 24
postinoculation (PI) and analyzed for serum PPRS virus,
interferon (IFN) activity, and alpha-1-acylglycoprotein
(AGP) concentrations.  Serum virus and IFN peaked at
105 virus/mL and 57% protection, respectively, at 4 d PI
and then declined steadily.  Serum AGP concentration
peaked at 12 d PI.  As dietary genistein concentration
increased, serum concentrations of PRRS virus decreased
linearly  (102.46, 102.26, 102.05, 102.14 virus per mL of serum,
P < .07) and IFN responded quadratically (28.4, 25.7,
22.8, 30.9% protection, P < .06) independent of d PI.
AGP concentrations increased (P < .01) quadratically
with the magnitude of the response to dietary genistein
maximized at 12 to 16 d PI.  Effects of dietary genistein
on daily pig gain and feed intake were dependent on
dietary genistein concentration and stage of viremia.
Daily pig gains from d 0 to 24 postinoculation were
improved quadratically (243, 281, 250, 246 g, P < .07) as
dietary genistein increased, but the magnitude of the
response to dietary genistein concentration lessened as the
serum virus concentrations were minimized.  Daily feed
intakes also were improved quadratically (315, 371, 345,
317 g, P < .05) as genistein concentration increased.
These data indicate that dietary soy genistein at 200 to
400 ppm is an orally active immune modulator that
enhances systemic serum virus elimination and body
growth in virally challenged pigs.
Introduction
Isoflavones are a subgroup of flavonoids found
predominantly in soybeans and clover (9) with
concentrations ranging from 100 to 5000 ppm (14).  Soy
isoflavones have been shown to elicit antioxidant and
estrogenic effects (5).  One primary isoflavone found in
soybeans and soy feed products (e.g., soybean meal) is
genistein.  In vitro, genistein elicits potential positive and
negative immune modulating effects.  Low concentrations
of genistein in vitro have been reported to elicit greater
natural killer cell activity (17) and antiviral replication
and/or attachment (16).  High concentrations of genistein
in vitro have been reported to reduce macrophage and
natural killer cell and phagocytosis rates through the
inhibition of tyrosine kinase activity (12) and to lower T
and B lymphocyte production through the suppression of
topoisomerase II (1).
Therefore, the objective of this study was to quantify
the effects of dietary genistein on pig growth and immune
response during a viral challenge.
Materials and Methods
Animals
The 12 sets of four littermate pigs from a high lean
strain were obtained from a herd naïve (noninfected,
nonvaccinated) for porcine reproductive and respiratory
syndrome (PRRS) virus.  The pigs were weaned at 10 ± 2
d of age and penned individually on slotted floors in 61 ×
122-cm pens.  Pigs were reared in the disease isolation
rooms at the National Animal Disease Center (NADC),
Ames, IA, to minimize the animals’ exposure to other
antigens. During the first 3 days after weaning, each pig
was administered intramuscularly with 4.4 mg of Naxcel
per kg of BW/day. Subsequently, no therapeutic or
subtherapeutic antimicrobial agents were provided.  A
thermal climate of 29 to 24°C was maintained.
At weaning, the pigs were randomly allotted within
litter to a basal diet (68 ppm genistein) supplemented with
one of four dietary concentrations of genistein (0, 200,
400, 800 ppm).  The diets contained nutrient
concentrations that met or exceeded the estimated nutrient
requirements of high lean pigs (8).  Pigs were allowed to
consume feed and water ad libitum.
Nineteen days following weaning, the pigs were
oronasally inoculated with 104.3 PRRS virus/mL from
strain JA142 in a 2-mL dose (courtesy of William
Mengeling, ARS-NADC, Ames, IA). Feed intake and
gain were measured every 4 d pre- and postinoculation
(PI).  Blood samples were collected via jugular
venipuncture prior to inoculation and every 4 d PI for
determination of serum concentrations of virus, interferon
(IFN), and alpha-1-acylglycoprotein (AGP).
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Blood samples also were collected prior to
inoculation and every 8 days PI to determine plasma
endotoxin levels. Body temperatures were measured by
using a digital rectal thermometer every 4 d PI.  Blood
was collected at weaning, inoculation, and at the removal
from test (15 ± 2 kg BW) for serological titer analysis for
five major swine pathogens: Actinobacillus
pleuropneumoniae, Mycoplasma hyopneumoniae, PRRS
virus, swine influenza, and transmissible gastroenteritis
virus.
Pigs were euthanized at a BW of 15 ± 2 kg.  Spleens
and thymus glands were rapidly removed and weighed.
Prior to inoculation, two pigs were euthanized due to
refusal to consume feed.  Postinoculation, one pig died
due to a twisted gut, and a second pig was euthanized due
to a joint infection. The Committee on Animal Care at
NADC approved the animal care procedures used.
Experimental Diets
The basal diet consisted of a corn, soy concentrate,
and whey mixture fortified with minerals and vitamins
(Table 1).  The experimental diets consisted of the basal
diet supplemented with 0, 200, 400, or 800 ppm genistein.
Genistein was provided primarily in the glycone form,
genistin, as an 88.8% pure extract (Wiley Organics,
Coshocton, OH) from soybeans.  The genistein contents
of the basal diet and genistein extract were analyzed via
high-performance liquid chromatography (14) and
reported in Table 2.  The analyzed concentrations of
genistein on an aglycone equivalent basis in the
experimental diets were 68, 254, 490, and 811 ppm,
respectively.
Serological Antibodies to Common Swine Pathogens
The presence of serum antibody titers for PRRS,
transmissible gastroenteritis, swine influenza virus, M.
hyopneumoniae, and A. pleuropneumoniae were
determined by the Iowa State University Veterinary
Diagnostic Laboratory, Ames, according to methods
outlined by Greiner et al. (4).  These samples were taken
to verify that the animals did not have passive or active
titers for PRRS prior to inoculation and to determine
whether the pigs were exposed to other prevalent pig
antigens during the study.
Serum Virus and Immune Parameters
Serum PRRS virus concentrations were analyzed by
using the procedures provided by William Mengeling,
USDA/ARS/NADC as described by Greiner et al. (4).
Serum IFN concentrations were assayed by using a
modified cell bioassay (10) as described by Greiner et al.
(4).  A 1:32 dilution was used in the assay.  Interferon-
gamma represented an average of 62% of the total IFN
present in the serum.  Serum AGP concentrations were
analyzed via a radial-immunodiffusion assay (Cardiotech
Services, Inc., 3027 Sherbrooke Rd., Louisville, KY
40205) as described by Greiner et al. (4).  The plasma
endotoxin was analyzed by a Limulus Amebocyte Lysate
(LAL) ELISA colorimetric kit (DiaPharma, Franklin,
OH).  The endotoxin recovery in the assay was 75%, and
the detection sensitivity of the assay was .005–1.2
endotoxin units/mL.
Data Analysis
Pigs were placed into blocks by litters and then
randomly allotted within litter to one of four dietary
treatments.  Data were analyzed as a randomized
complete block design by analysis of variance technique
using the GLM procedure of SAS (11).  Pig weight at
inoculation was used as a covariate when analyzing pig
performance and immune response PI.  Responses of
body weight gain, feed intake, gain:feed, serum
concentrations of virus, IFN, and AGP, as well as plasma
concentration of endotoxin over the 4-d periods were
analyzed as repeated measures.  The error terms used to
test the effects of genistein, period, and genistein × period
were, respectively, replicate × genistein, replicate ×
period, and replicate × genistein × period.  The pig was
considered the experimental unit.  Data are reported as
least square means.
Table 1.  Basal diet composition (%).
Ingredient                 % of Diet
Corn, yellow 36.74
Soy protein concentrate 28.83
l-Lysine, HCl .20
l-Threonine .15
d,l-Methionine .30
Tryptosine .15
Whey, dried 20.00
Skim milk, dried 5.00
Choice white grease 4.00
Dicalcium phosphate 2.73
Limestone .33
Salt .40
Choline chloride (60%)a .20
Selenium .05
Trace mineral/vitamina  .52
Genistein carrier b .40
a Provided the following per kg of diet:  Biotin .15 mg,
Choline chloride 1,813 mg, Folacin 1.8 mg, Niacin 90
mg, Pantothenic acid 60 mg, Riboflavin 21 mg,
Pyridoxine 4.5 mg, Thiamin 3 mg, Vitamin A 13,200 IU,
Vitamin D3 1,320 IU, Vitamin E 96 IU, Vitamin K 3 mg,
Vitamin B12 105 µg, Vitamin C 100 mg, Zn 212 mg, Cu
17.5 mg, Fe 175 mg, Mn 60 mg, I .20 mg.
b Genistein source added at the expense of corn starch
carrier.
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Results and Discussion
Serological Titer Status
Serological results confirmed that pigs were PRRS
naïve at weaning and immediately prior to inoculation.
Based on the level of serum antibody titers, pigs also were
naïve for A. pleuropneumoniae and M. hyopneumoniae at
weaning, preinoculation, and at 15 kg BW.  Passively
acquired antibody titers for transmissible gastroenteritis
virus and swine influenza virus were present in 50 and
58% of the pigs at weaning and inoculation, respectively;
these amounts subsequently declined to 25 and 42% of
the animals at 15 kg BW.
Effect of Virus Inoculation
Pigs were not infected until after 21 d of age to
ensure that the immune system was developed and
functional in the experimental animals (13).  Pigs were
fed their experimental diets pre- and postinoculation to
allow potential effects of genistein on the animals’ initial
susceptibility to the virus, as well as the animals’
subsequent ability to eliminate the virus PI, to be
expressed.
Within 4 d PI, pigs experienced elevated body
temperature (≅40.6°C), coughing, and anorexia. PRRS
virus was detected in serum for 100% of the pigs at d 4.
By d 24 PI, PRRS virus was only detected in 50% of the
pigs.  Serum viral concentration peaked at 4 d PI and then
declined linearly (Figure 1).  Serum concentrations of
IFN, which has antiviral effects and can stimulate
macrophage activity, peaked at 4 d PI in correspondence
with virus concentration.  Serum AGP, however, did not
peak until 8 to 12 d PI.  This response was expected,
because AGP is produced by the liver in response to the
release of cytokines IL-1, IL-6, and TNF-α from the
macrophages and requires 8 to 12 d to be synthesized and
released into circulation (7).  Serum concentration of
endotoxin remained low during the 24-d PI period,
indicating that a secondary Escherichia coli infection did
not occur (Figure 2).
Postinoculation, daily pig gain decreased from 250 g
for the 4-d period prior to inoculation to 100 g for the
initial 4-d period PI.  Subsequently, daily pig gain
increased gradually but did not exceed 250 g until d 12 PI
(Figure 3).  Feed intake also was suppressed PI (Figure 4).
Based on these data, we find that the viral exposure
used in the current study created a prolonged and
substantial immune response and resulted in growth
inhibition.
Dietary Genistein and Genistein x Day PI Effects
From weaning to inoculation, pig gain and feed
intake were decreased at the highest dietary genistein
concentrations increased (Table 3).  But pig weight at day
of inoculation did not differ among dietary treatment
groups (P > .3).
Postinoculation, incremental additions of dietary
genistein resulted in a linear reduction (P < .07) in serum
concentration of virus (Figure 5) and quadratic reductions
(P < .06) in serum concentrations of IFN (Table 4).
These responses were independent of d PI.  Dietary
genistein additions also resulted in an increase in serum
concentration of AGP during the periods of high viremia;
however, this response was eliminated as serum virus
concentration declined, resulting in a quadratic genistein
concentration by period interaction (Figure 6, P < .01).
Postinoculation, dietary genistein additions improved
daily pig gain and daily feed intake, but the magnitude of
the response was dependent on the genistein
concentration and days PI.  Specifically, BW gain and
feed intake during the stages of high viremia (d 4 to 12
PI) improved quadratically as dietary genistein
concentration increased from 0 to 800 ppm with the
greatest improvement occurring at the 200 ppm group
(Table 4).  Responses to 400 and 800 ppm genistein were
minimized during stages of low viremia (d 16 to 24 PI)
resulting in a dietary genistein by period interaction
(Figure 7).
As dietary concentrations of soy genistein increased,
thymus weight was not altered (P > .80), but spleen
weight was increased (P < .01) linearly (Table 4).  The
increase in spleen weight is indicative of a greater B cell
production.  This response was in agreement with the
greater AGP concentration in genistein-fed pigs during
the infection period.
The lack of a genistein by day interaction indicates
that the serum virus concentration was reduced at 4 d PI
by genistein and that the subsequent rate of virus
elimination among dietary treatment groups was similar.
The lack of interaction indicates that the feeding of
genistein preinoculation aided the pig’s ability to initially
resist virus infection.  The greater AGP response in the
genistein-fed pigs supports the hypothesis of a greater and
more effective immune response, which in turn was
associated with a lower virus infection in these animals.
The lower level of virus infection in the genistein-fed pigs
was associated with increased body growth and voluntary
feed intake, particularly during periods of high viremia.
These responses mimic the improved growth rates
observed in pigs as the level of chronic subclinical
pathogen exposure is minimized (15).
In addition, the reduction in the level of viremia and
the associated improvement in both pig gain and feed
intake is supported by the regression equation
demonstrated in Greiner et al. (4).  Greiner et al. (4)
demonstrated that by minimizing the level of serum virus
concentration by one log within the first 4 d PI, the
expected increase 4-d pig gain would be .047 kg.  The
reduction in serum virus concentration associated with
improved pig performance occurred in this experiment
with all three genistein-supplemented treatments,
indicating that genistein addition will improve pig gain
during stages of viremia by minimizing, not eliminating,
the serum concentration of virus.
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Potential Role of Genistein on Reducing Virus
Concentration
The effect of dietary genistein on reducing virus
concentration may be related to its effect on the function
and intercellular signaling capacity of immune cells
and/or the ability of the virus to replicate or attach.  In
vitro, low concentrations of genistein (.5–5 µM) stimulate
natural killer (NK) cell activity (17), which has a key role
in pathogen clearance (7).  Through the activity of NK
cells, the pathogen is more rapidly removed from the
body, which allows the animal to return to its state of
health prior to infection (7).  Genistein also has been
shown in vitro at concentrations of more than 25 µM to
inhibit the protein replication or attachment of the herpes
virus (16).  Previous work at our station has shown that
dietary genistein additions of 120 to 920 ppm result in
serum concentrations of .5 to 3.5 µM in pigs (2).  These
serum concentrations represent bioactive levels based on
the work of Zhang et al. (17).
The lower serum IFN concentrations in genistein-fed
animals are in agreement with the greater virus
elimination and potentially more rapid return of IFN
secretion to baseline levels because IFN is released by T
cytotoxic, T helper, and NK cells in animals exposed to
virus (4).  The more rapidly and efficiently the virus is
eliminated, the more rapidly the IFN release is reduced
because IFN is released during a pathogen challenge (4).
The lower IFN concentration could also be due in part to
a genistein-induced inhibition of PGE2 production (3).
Because of the 8- to 12-d delay in AGP synthesis and
release after a pathogen exposure, the greater serum AGP
concentrations 8 to 12 d PI in pigs fed genistein indicates
a greater initial capacity of the genistein-fed pigs to
mount an immune response.  The AGP response is due to
the fact that AGP is produced due to increased B cell
stimulating cytokines (4).  The rapid return of serum AGP
concentration to baseline values in the genistein-fed pigs
is compatible with the lower serum virus concentration
expressed in these pigs.
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Figure 1.  Mean serum concentrations of porcine
reproductive and respiratory syndrome virus (PRRS,
10x/mL) from d 0 to 24 postinoculation in 48 pigs.
Data pooled across dietary genistein concentrations.
Figure 2. Plasma concentration of endotoxin (ng/mL)
from d 0 to 24 postinoculation.  Pooled across dietary
soy genistein concentration.
Figure 3. Daily pig gain (g) during 4-d periods from -8
to 24 d postinoculation.  Data pooled across dietary
soy genistein concentrations.
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Figure 4. Daily feed intake (g) during 4-d periods from
-8 to 24 d postinoculation.  Data pooled across dietary
soy genistein concentration.
Figure 5. Effect of dietary soy genistein (G)
concentration on serum concentration of virus
(10x/mL) from d 0 to 24 postinoculation.
Figure 6. Effect of dietary soy genistein (G)
concentration on serum concentration of alpha-1-
acylglycoprotein (µg/mL) from day (D) 0 to 24
postinoculation.
Figure 7. Effect of dietary soy genistein (G)
concentration on daily pig gain (g) during 4-d periods
from day (D) 0 to 24 postinoculation.
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Table 2.  Genistein composition of the basal diet
and genistein source.
            As Is Basis,         Aglycone
           ppm         Equivalent
         Basal   Genistein    Basal
Genistein
Isoflavone  Diet Source      Diet   Source
Genistein
Malonyl genistin 19 0 10 0
Acetyl genistin 35 0 20 0
Genistin 34 899,000 21 562,000
Genistein 17 9,000 17 9,000
Total 105 908,000 68 571,000
Daidzein
Malonyl daidzin 15 0 10 0
Acetyl daidzin 25 0 10 0
Daidzin 20 96,000 10 59,000
Daidzein 0 7,000 0 1,000
Total 60 103,000 30 60,000
Glycitin
Malonyl glycitin 0 0 0 0
Acetyl glycitin 0 0 0 0
Glycitin 0 20,000 0 13,000
Glycitein 0 14,000 0 1,000
Total 0 34,000 0 14,000
Table 3.  Effect of dietary genistein on pig
performance from weaning to inoculationa.
      Dietary Genistein Concentration, ppm
Criteria 0 200 400 800 Pb   SEM
Number of pigs 12 11 11 10
Pig weight preinoculation, kg
   Weaning 3.14 3.16 3.16 3.13 .99 .06
   Inoculation 5.52 5.62 5.48 4.68 .30 .16
Pig gain and Feed Utilization
   Gain, g/d 163 166 165 118 .06L 25
   Feed, g/d 192 189 187 146 .03L 7
   Gain:feed, g/kg 734 843 947 698 .02Q 40
a  Least square means reported.
b  Linear (L), quadratic (Q), or cubic (C) effect of dietary
genistein concentration.
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Table 4.  Effect of dietary genistein on pig
performance and immune parameter from d 0 to 24
postinoculation (PI) a.
Dietary Genistein Concentration, ppm
Criteria 0 200 400 800   Pb    SEM
No. of pens 12 11 11 10
Pig weight postinoculation, kg
   D 0 PI  5.52 5.62 5.48 4.68 .30 .31
   D 24 PI 11.47 12.68 11.51 10.42 .12L .18
Pig gain and Feed Utilization (Pooled across d 0 to 24 PI)c
Gain, g/d 243 281 250 246 .10C 7
Feed, g/d 315 371 345 317 .05Q 9
Gain:feed, g/kg 759 765 723 793 .13 10
Serum Immune Parameters (Pooled across d 0 to 24 PI) c
Virus, 10x/mL 2.46 2.26 2.05 2.14 .07L .06
IFN, % 28.4 25.7 22.8 30.9 .06Q 1.32
AGP, µg/mL 524 529 531 538 .20 5.15
Immune organ weights, g (at 15 kg BW) c
Spleen 70 66 79 81 .01L 2
Thymus 61 62 55 62 .80 2
a  Least square means reported.
b  Linear (L), quadratic (Q), or cubic (C) effect of dietary
genistein (G) concentration.
c  Pig body weight at d 0 PI used as covariate.
